Over the past three decades, a limited number of individuals have been reported with genetic defects in the CD19 gene, resulting in impaired B cell differentiation and function, and leading to an autosomal recessive form of hypogammaglobulinemia that closely resembles common variable immunodeficiency (CVID) (9, 10). This evidence concerns the gene CD19 and agammaglobulinemia.